The Impact of Tumor Volume Burden Reduction for Pediatric Solid Tumors by Immune Checkpoint Inhibitors

被引：0
|
作者：
Saito, Takeshi [1 ,2 ]
Fuchimoto, Yasushi [2 ]
Fukui, Keisuke [2 ]
Shimizu, Takahiro [3 ]
Kuroda, Tatsuo [4 ]
Hirabayashi, Takeshi [1 ]
Hakamada, Kenichi [1 ]
机构：
[1] Hirosaki Univ Hosp, Dept Pediat Surg, Aomori, Japan
[2] Int Univ Hlth & Welf Hosp, Dept Pediat Surg, Otawara, Tochigi, Japan
[3] Tokai Univ, Sch Med, Dept Pediat Surg, Hiratsuka, Kanagawa, Japan
[4] Keio Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS35-3-4
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math
    Frank A. Giordano
    Marlon R. Veldwijk
    Carsten Herskind
    Frederik Wenz
    Strahlentherapie und Onkologie, 2018, 194 : 873 - 875
  • [22] Immune checkpoint inhibitors and tumor mutation burden as predictive biomarkers in hepatocellular carcinoma
    Shrestha, R.
    Prithviraj, P.
    Bridle, K. R.
    Crawford, D. H. G.
    Anaka, M.
    Jayachandran, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 31 - 31
  • [23] Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math
    Giordano, Frank A.
    Veldwijk, Marlon R.
    Herskind, Carsten
    Wenz, Frederik
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (10) : 873 - 875
  • [24] Thymic tumors and immune checkpoint inhibitors
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1509 - S1515
  • [25] Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors
    Yu, James
    Park, Robin
    Miao, Ruoyu
    Imanirad, Iman
    Shahzad, Moazzam
    Laborde, Jose M.
    Knepper, Todd C.
    Walko, Christine M.
    Kim, Richard
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (09) : 378 - 383
  • [26] Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors
    Adrian Bubie
    Edgar Gonzalez-Kozlova
    Nicholas Akers
    Augusto Villanueva
    Bojan Losic
    Scientific Reports, 10
  • [27] Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors
    Bubie, Adrian
    Gonzalez-Kozlova, Edgar
    Akers, Nicholas
    Villanueva, Augusto
    Losic, Bojan
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
    Takuma Matoba
    Kiyoshi Minohara
    Daisuke Kawakita
    Gaku Takano
    Keisuke Oguri
    Akihiro Murashima
    Kazuyuki Nakai
    Sho Iwaki
    Hiroshi Tsuge
    Nobukazu Tanaka
    Sae Imaizumi
    Wataru Hojo
    Ayano Matsumura
    Koji Tsukamoto
    Shinichi Esaki
    Shinichi Iwasaki
    Scientific Reports, 12
  • [29] Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors
    Matoba, Takuma
    Minohara, Kiyoshi
    Kawakita, Daisuke
    Takano, Gaku
    Oguri, Keisuke
    Murashima, Akihiro
    Nakai, Kazuyuki
    Iwaki, Sho
    Tsuge, Hiroshi
    Tanaka, Nobukazu
    Imaizumi, Sae
    Hojo, Wataru
    Matsumura, Ayano
    Tsukamoto, Koji
    Esaki, Shinichi
    Iwasaki, Shinichi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] Repurposing drugs for solid tumor treatment:focus on immune checkpoint inhibitors
    Qingxu Liu
    Long Li
    Wan Qin
    Tengfei Chao
    Cancer Biology & Medicine, 2023, (11) : 856 - 868
12345